Is there a paradigm shift in use of microsomes and hepatocytes in drug discovery and development?
Opinion
Saved in:
Main Authors: | Sumit Basu (Author), Abdul Naveed Shaik (Author) |
---|---|
Format: | Book |
Published: |
International Association of Physical Chemists (IAPC),
2016-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Similar Items
-
Changing trends in use of hepatocytes and microsomes for evaluating metabolism studies in drug discovery
by: Abdul Naveed Shaik
Published: (2016) -
Role of drug transporters in drug development: a qualitative and quantitative approach
by: Sumit Basu, et al.
Published: (2017) -
Accelerating Therapeutics for Opportunities in Medicine: A Paradigm Shift in Drug Discovery
by: Izumi V. Hinkson, et al.
Published: (2020) -
Physiologically based pharmacokinetic (PBPK) modeling and simulation in drug discovery and development
by: Abdul Naveed Shaik, et al.
Published: (2019) -
Integrating Artificial Intelligence and PET Imaging for Drug Discovery: A Paradigm Shift in Immunotherapy
by: Jeremy P. McGale, et al.
Published: (2024)